The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder
- 5 December 2009
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 28 (3-4) , 345-353
Abstract
Intravesical Mycobacterium bovis bacillus Calmette–Guérin (BCG) immunotherapy is a highly effective treatment for carcinoma in situ of the bladder, as well as high-risk nonmuscle invasive urothelial carcinoma of the bladder. Despite over 30 years of clinical experience with BCG, the therapy’s mechanism has remained enigmatic. Observations regarding the role of neutrophils in BCG immunotherapy have led to exciting discoveries regarding the potential role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in creating the therapeutic benefit of BCG immunotherapy. In this paper, we will review the scope of the disease, highlight our understanding of the role for BCG in urothelial carcinoma of the bladder, explain the recent discoveries regarding the role of neutrophils and TRAIL in therapy, and theorize on potential future areas of research.Keywords
This publication has 79 references indexed in Scilit:
- Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder CancerJNCI: Journal of the National Cancer Institute, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Four Cases of Disseminated Mycobacterium bovis Infection Following Intravesical BCG Instillation for Treatment of Bladder CarcinomaSouthern Medical Journal, 2008
- Identification of the Mycobacterial Subcomponents Involved in the Release of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand from Human NeutrophilsInfection and Immunity, 2007
- The pathology of bladder cancer: an update on selected issuesBJU International, 2006
- Fluorescence cystoscopy: is it ready for use in routine clinical practice?Current Opinion in Urology, 2006
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology, 1996
- Priorities for Future IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.Environmental Health Perspectives, 1994